Viewing Study NCT00885066


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-01-01 @ 4:10 PM
Study NCT ID: NCT00885066
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2009-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Sponsor: Centre Antoine Lacassagne
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-05
Start Date Type: None
Primary Completion Date: 2009-09
Primary Completion Date Type: ACTUAL
Completion Date: 2009-10
Completion Date Type: ACTUAL
First Submit Date: 2009-04-18
First Submit QC Date: None
Study First Post Date: 2009-04-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-29
Last Update Post Date: 2025-09-30
Last Update Post Date Type: ESTIMATED